BACRP
BANK OF AMERICA CORP /DE/
$185.77
0.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Apr 20, 2026
SEC
Bank of America issued $10 billion in medium-term notes across four series: $500 million in floating-rate senior notes,
424B5 — Impact 5/10
Apr 15, 2026
SEC
Bank of America reported Q1 2026 earnings with net income of $8.6 billion ($1.11 EPS), up 17% and 25% YoY respectively,
8-K — Impact 8/10
Apr 3, 2026
SEC
Bank of America is holding its 2026 annual shareholder meeting, where management is seeking approval for the election of
DEFA14A — Impact 4/10
Analyst Ratings
7Strong Buy
17Buy
5Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
424B5
5/10
Bank of America issued $10 billion in medium-term notes across four series: $500 million in floating-rate senior notes,
Apr 20, 2026
BULLISH
8-K
8/10
Bank of America reported Q1 2026 earnings with net income of $8.6 billion ($1.11 EPS), up 17% and 25% YoY respectively,
Apr 15, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.7/10.
NEUTRAL
424B5
5/10
Bank of America issued $10 billion in medium-term notes across four series: $500 million in floating
Apr 20, 2026
BULLISH
8-K
8/10
Bank of America reported Q1 2026 earnings with net income of $8.6 billion ($1.11 EPS), up 17% and 25
Apr 15, 2026
NEUTRAL
DEFA14A
4/10
Bank of America is holding its 2026 annual shareholder meeting, where management is seeking approval
Apr 3, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 83% buy across 29 analysts — 7 strong buy, 17 buy, 5 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 7 | 17 | 5 | 0 | 0 | 83% | |
| May 1, 2026 | 7 | 18 | 5 | 0 | 0 | 83% | |
| Apr 1, 2026 | 6 | 20 | 5 | 0 | 0 | 84% | |
| Mar 1, 2026 | 5 | 19 | 6 | 0 | 0 | 80% | |
| Feb 1, 2026 | 5 | 19 | 6 | 0 | 0 | 80% | |
| Jan 1, 2026 | 6 | 18 | 5 | 0 | 0 | 83% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.